Medical Properties Trust (MPT) Q2 2024 earnings summary

Executive summary

• Generated over $2.5 billion in liquidity year-to-date, exceeding initial targets and enabling expedited debt paydown.

• Reported net loss of $320.6 million for Q2 2024, driven by $960 million in Steward-related impairments and fair value adjustments, despite $1.3 billion in asset sale proceeds.

• Portfolio performance remains strong, with most assets performing well and strategic focus on value realization.

• Steward Health Care's Chapter 11 restructuring is ongoing, with Massachusetts properties exited and significant uncertainty regarding asset recoverability.

• Completed major asset sales and joint ventures, including $1.1 billion from Utah hospitals and $350 million from Prime Healthcare.

Financial highlights

• Q2 2024 revenues: $266.6 million, down 21% year-over-year, with a reported GAAP net loss of $0.54 per share and normalized FFO of $0.23 per share.

• Q2 results included $19 million in consolidated cash revenue from Steward and $22 million from Prospect.

• Approximately $960 million in non-cash impairment charges, mainly from Steward and Massachusetts partnership equity stake.

• Adjusted downward the book value of the PHP Holdings investment by $163 million and recorded a $360 million negative fair value adjustment.

• Cash and cash equivalents at June 30, 2024: $606.6 million.

Outlook and guidance

• Management expects to meet debt covenants through asset sales, cash retention, and capital access, but notes risk if further extensions are not approved.

• Expectation to have a stable portfolio with no Steward exposure by 2026, with multiple options to satisfy maturing loans.

• Dividend payout limited to $0.08 per share per quarter in cash through Q3 2025, with a normalized FFO payout ratio of about 35%.

• No material real estate acquisitions expected in the near term; focus remains on liquidity and debt reduction.